Ontology highlight
ABSTRACT: Background
Multiple iterations of chimeric antigen receptors (CARs) have been developed, mainly focusing on intracellular signaling modules. However, the effect of non-signaling extracellular modules on the expansion and therapeutic efficacy of CARs remains largely undefined.Methods
We generated two versions of CAR vectors, with or without a hinge domain, targeting CD19, mesothelin, PSCA, MUC1, and HER2, respectively. Then, we systematically compared the effect of the hinge domains on the growth kinetics, cytokine production, and cytotoxicity of CAR T cells in vitro and in vivo.Results
During in vitro culture period, the percentages and absolute numbers of T cells expressing the CARs containing a hinge domain continuously increased, mainly through the promotion of CD4+ CAR T cell expansion, regardless of the single-chain variable fragment (scFv). In vitro migration assay showed that the hinges enhanced CAR T cells migratory capacity. The T cells expressing anti-CD19 CARs with or without a hinge had similar antitumor capacities in vivo, whereas the T cells expressing anti-mesothelin CARs containing a hinge domain showed enhanced antitumor activities.Conclusions
Hence, our results demonstrate that a hinge contributes to CAR T cell expansion and is capable of increasing the antitumor efficacy of some specific CAR T cells. Our results suggest potential novel strategies in CAR vector design.
SUBMITTER: Qin L
PROVIDER: S-EPMC5347831 | biostudies-literature | 2017 Mar
REPOSITORIES: biostudies-literature
Qin Le L Lai Yunxin Y Zhao Ruocong R Wei Xinru X Weng Jianyu J Lai Peilong P Li Baiheng B Lin Simiao S Wang Suna S Wu Qiting Q Liang Qiubin Q Li Yangqiu Y Zhang Xuchao X Wu Yilong Y Liu Pentao P Yao Yao Y Pei Duanqing D Du Xin X Li Peng P
Journal of hematology & oncology 20170313 1
<h4>Background</h4>Multiple iterations of chimeric antigen receptors (CARs) have been developed, mainly focusing on intracellular signaling modules. However, the effect of non-signaling extracellular modules on the expansion and therapeutic efficacy of CARs remains largely undefined.<h4>Methods</h4>We generated two versions of CAR vectors, with or without a hinge domain, targeting CD19, mesothelin, PSCA, MUC1, and HER2, respectively. Then, we systematically compared the effect of the hinge domai ...[more]